Higher serum C-reactive protein levels predict a worse outcome in patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure

A. M. Brambilla, S. Aliberti, P. Tarsia, C. Canetta, G. Graziadei, G. Milani, L. Grazioli, E. R. Bregani, G. Torgano, R. Cosentini (Milan, Italy)

Source: Annual Congress 2004 - Treatment and outcome of acute respiratory failure
Session: Treatment and outcome of acute respiratory failure
Session type: Thematic Poster Session
Number: 671

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. M. Brambilla, S. Aliberti, P. Tarsia, C. Canetta, G. Graziadei, G. Milani, L. Grazioli, E. R. Bregani, G. Torgano, R. Cosentini (Milan, Italy). Higher serum C-reactive protein levels predict a worse outcome in patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure. Eur Respir J 2004; 24: Suppl. 48, 671

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Higher serum lactic deydrogenase (LDH) levels predict a worse outcome in patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure (CPAP)
Source: Eur Respir J 2004; 24: Suppl. 48, 92s
Year: 2004

C-reactive protein levels and clinically important predictive outcomes in stable COPD patients
Source: Eur Respir J 2006; 27: 902-907
Year: 2006



Risk factors of mortality in patients with acute cardiogenic pulmonary edema (ACPE) treated with continuous positive airway pressure (CPAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 263s
Year: 2007

Procalcitonin and C-reactive protein levels correlate worse with organ failure than NT-proBNP levels in septic patients
Source: Eur Respir J 2006; 28: Suppl. 50, 61s
Year: 2006

Elevated blood eosinophils on admission for a severe exacerbation of COPD is not a predictor for survival
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017

Elevated cardiac troponin I levels in acute pulmonary embolism predict increased long-term mortality
Source: Eur Respir J 2005; 26: Suppl. 49, 271s
Year: 2005

Effect of continuous positive airway pressure treatment on elevated levels of C-reactive protein in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 330s
Year: 2004

Use of new simplified acute physiology score (SAPS II) in patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure
Source: Eur Respir J 2004; 24: Suppl. 48, 92s
Year: 2004

Effect of serum NT-proBNP and H-FABP levels in predicting extent of acute pulmonary thromboembolism
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders
Year: 2010

Increased serum endotoxin levels as biomarker in acute exacerbations of COPD.
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018

Independent contribution of C-reactive protein and oxygen status of arterial blood to tissue hypoxia in stable COPD patients
Source: Eur Respir J 2007; 30: Suppl. 51, 771s
Year: 2007

The role of plasma D-dimer level to detect pulmonary embolism in COPD exacerbation
Source: Annual Congress 2007 - Pulmonary circulation
Year: 2007


C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary circulation
Year: 2009


Role of brain natriuretic peptide levels in predicting the acute clinical worsening episodes and response to iloprost infusion in patients with pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009


Factors affecting C-reactive protein levels in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007


The importance of C-reactive protein in patients with acute exacerbation of severe COPD
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019

Elevated pulmonary vascular resistance predicts mortality in COPD patients
Source: Eur Respir J, 58 (2) 2100944; 10.1183/13993003.00944-2021
Year: 2021



Study on levels of high sensitivity C reactive protein in asthmatic patients during exacerbation and remission and its correlation with pulmonary function
Source: Annual Congress 2007 - Mechanisms of airway inflammation
Year: 2007



The relationship between level of C-reactive protein in blood serum and clinical manifestations of the disease in patients with pulmonary tuberculosis
Source: Annual Congress 2010 - Tuberculosis: metabolic insights
Year: 2010

Evaluation of high sensitivity C reactive protein in patients of bronchial asthma and its correlation with exacerbation rate and pulmonary function
Source: Annual Congress 2008 - Asthma: growing understanding of influential factors
Year: 2008